What is the initial workup for a patient with secondary hypertension from a nephrology perspective?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Secondary Hypertension Workup from a Nephrology Perspective

All patients with confirmed hypertension should be screened with a plasma aldosterone-to-renin ratio (ARR), as primary aldosteronism is the most common treatable renal cause of secondary hypertension, affecting 8-20% of resistant hypertension cases. 1, 2

When to Suspect Secondary Hypertension

Pursue aggressive workup in these clinical scenarios:

  • Age of onset <30 years (or <40 years per ESC 2024 guidelines) 1, 3
  • Resistant hypertension: BP >140/90 mmHg despite optimal doses of ≥3 antihypertensive drugs including a diuretic 1, 2
  • Sudden onset or sudden deterioration of previously controlled hypertension 1, 3
  • Hypertensive urgency or emergency 1, 3
  • Target organ damage disproportionate to duration or severity of hypertension 1

Initial Laboratory Screening (Complete Before Imaging)

Basic panel for all suspected cases:

  • Plasma aldosterone-to-renin ratio (ARR) - most critical test, now recommended for all confirmed hypertension 1, 2, 3
  • Serum electrolytes (sodium, potassium) - hypokalemia strongly suggests primary aldosteronism 1, 3
  • Serum creatinine and eGFR 1, 3
  • Urinalysis with microscopy - look for blood, protein, and casts suggesting renal parenchymal disease 1, 3
  • Urinary albumin-to-creatinine ratio 4, 1, 3
  • Fasting blood glucose or HbA1c 1, 3
  • Thyroid-stimulating hormone (TSH) 1, 3
  • 12-lead ECG - assess for left ventricular hypertrophy 4, 3

Renal-Specific Clinical Clues

Renal Parenchymal Disease

Look for history of:

  • Urinary tract infections, obstruction, hematuria 1
  • Urinary frequency, nocturia 1
  • Family history of polycystic kidney disease 1

Renovascular Disease (Renal Artery Stenosis)

Suspect when:

  • Abrupt onset or worsening hypertension 1, 3
  • Flash pulmonary edema 1, 3
  • Serum creatinine increase ≥50% within one week of starting ACE inhibitor or ARB 3, 5
  • Severe hypertension with unilateral smaller kidney or kidney size difference >1.5 cm 3, 5
  • Abdominal systolic-diastolic bruit on examination 3

Targeted Renal Imaging

Only proceed after completing basic laboratory screening to avoid expensive unnecessary imaging 1, 3

For Renovascular Disease:

  • Initial: Renal Duplex Doppler ultrasound 4, 2
  • Confirmatory: CT or MRI renal angiography 4, 2, 3

For Renal Parenchymal Disease:

  • Renal ultrasound to assess kidney size, echogenicity, and structural abnormalities 4

Confirmatory Testing for Primary Aldosteronism

When ARR is positive (ratio >20 with elevated aldosterone and suppressed renin):

  • Confirmatory tests: Oral sodium loading test with 24-hour urine aldosterone OR IV saline infusion test with plasma aldosterone at 4 hours 3
  • Localization studies: Adrenal CT scan, followed by adrenal vein sampling if surgical intervention is considered 3

Critical Pitfalls to Avoid

  • Do not perform expensive imaging (CT, MRI, angiography) before completing basic laboratory screening 1, 3
  • Medications affect ARR interpretation: Mineralocorticoid receptor antagonists raise aldosterone; beta-blockers and direct renin inhibitors lower renin 1
  • Delayed diagnosis leads to vascular remodeling, affecting renal function and resulting in residual hypertension even after treating the underlying cause 1, 2
  • Never combine two RAS blockers (ACE inhibitor + ARB) due to increased risk of hyperkalemia, hypotension, and acute kidney injury 3

Management Based on Renal Causes

Primary Aldosteronism:

  • Unilateral disease: Laparoscopic adrenalectomy 1, 3
  • Bilateral disease: Spironolactone 50-100 mg daily 1, 3

Renovascular Disease:

  • Atherosclerotic renal artery stenosis: Medical therapy preferred (statin, antiplatelet, ACE inhibitor/ARB, cardiovascular risk optimization) 3
  • Fibromuscular dysplasia: Percutaneous transluminal renal angioplasty without stenting 1, 3

Renal Parenchymal Disease:

  • Address underlying renal disease with specific treatments 1
  • Monitor renal function carefully when using RAS blockers 1

Resistant Hypertension Protocol (After Excluding Secondary Causes)

  • Optimize diuretic therapy: Use thiazide-like diuretics (not classic thiazides); consider loop diuretics for eGFR <30 ml/min/1.73m² 1
  • Add spironolactone as fourth-line agent if K+ <4.5 mmol/L and eGFR >45 ml/min/1.73m² 1, 3
  • Consider renal denervation for resistant hypertension uncontrolled despite three-drug combination 1

Recognize that 5-10% of all hypertensive patients have secondary causes, increasing to 10-20% in resistant cases - maintain a high index of suspicion from a nephrology perspective. 3, 5

References

Guideline

Secondary Causes of Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ruling Out Secondary Causes of Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic and Treatment Orders for Secondary Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Secondary Hypertension: Discovering the Underlying Cause.

American family physician, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.